The rational design of affinity-attenuated OmCI for the purification of complement C5

Complement component C5 is the target of the mAb eculizumab and is the focus of a sustained drug discovery effort to prevent complement-induced inflammation in a range of autoimmune diseases. The immune evasion protein OmCI binds to and potently inactivates C5; this tight-binding interaction can be...

Descripción completa

Detalles Bibliográficos
Autores principales: Macpherson, Alex, Liu, Xiaofeng, Dedi, Neesha, Kennedy, Jeffery, Carrington, Bruce, Durrant, Oliver, Heywood, Sam, van den Elsen, Jean, Lawson, Alastair D. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2018
Materias:
Methods and Resources
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130949/
https://www.ncbi.nlm.nih.gov/pubmed/30030376
http://dx.doi.org/10.1074/jbc.RA118.004043

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130949/
https://www.ncbi.nlm.nih.gov/pubmed/30030376
http://dx.doi.org/10.1074/jbc.RA118.004043

Ejemplares similares